Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (125)
- Compliance and enforcement (33)
- Import and export (30)
- Shortages and supply disruptions (16)
- Sunscreens (9)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1291 result(s) found, displaying 1251 to 1275
-
Market actionsRecall due to failure to comply with the mandatory absorbency requirements of AS/NZS 2869:1988 Tampons - menstrual.
-
Safety alertsFact sheet to inform consumers about the safe use of paracetamol
-
Safety alertsThis fact sheet has been prepared by the Therapeutic Goods Administration to inform health practitioners about the safe use of paracetamol.
-
Market actionsRecall due to failure to comply with the requirements of TGO61 Contraceptive Rubber condoms.
-
-
Market actionsThe products have failed to comply with the relevant mandatory requirement for absorbency (AS/NZS 2869:1998 Tampons - Menstrual).
-
Market actionsIn 2003, the TGA recalled Pan Pharmaceuticals’ products due to serious safety and manufacturing issues.
-
Market actions
-
Market actions
-
-
Market actions
-
Market actions
-
Market actions
-
Market actions
-
Market actions
-
Market actions
-
Market actions
-
Safety alertsBotanicLab herbal supplements contain undeclared prescription drugs and are not registered in Australia. Stop using them and consult your doctor for advice.
-
Safety alertsDo not use homoeopathic meningococcal 'vaccines' as they don't protect against the disease. Use approved vaccines and talk to your doctor if you have any questions.
-
Safety alertsKava-containing medicines are under review due to reports of liver damage, and a voluntary recall has been initiated while we assess their safety.
-
Market actions
-
Safety alertsWe are advising that long-term use of oestrogen-only therapy may increase the risk of ovarian cancer. Consult your doctor if you have concerns.
-
Market actions
-
Safety alertsThe Expert Committee has reviewed the safety of HRT and found increased risks of heart attacks, strokes, blood clots, and breast cancer, outweighing the benefits for long-term disease prevention
-
Market actionsA limited number of scooters may experience premature failure of the drive mechanism. In the event of failure loss of drive and braking occurs.